ORANO MED
Orano Med develops a new generation of targeted cancer therapies. The Orano Med company specializes in performance chelating agents, offering a broad range of products and services. The Orano Med strategy centers on creating a solid portfolio of therapies and ensuring a reliable supply of isotopes.
ORANO MED
Industry:
Biotechnology Clinical Trials Health Care Pharmaceutical
Founded:
2009-01-01
Address:
Plano, Texas, United States
Country:
United States
Website Url:
http://www.oranomed.com
Total Employee:
51+
Status:
Active
Contact:
+1 469 638 0632
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Collagen Medical
Collagen Medical develops targeted magnetic resonance imaging contrast agents.
IDM Pharma
IDM develops immunotherapies for cancer
SixOne Solutions
First in class targeted therapy for metastatic breast cancer
Current Employees Featured
Founder
Official Site Inspections
http://www.oranomed.com
- Host name: 51.138.200.3
- IP address: 51.138.200.3
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
More informations about "Orano Med"
Orano Announces Leadership Transition in Orano Med
Paris, October 25, 2024 Orano is pleased to announce a significant evolution in the leadership structure of its subsidiary Orano Med, a pioneer in the development of targeted alphatherapies …See details»
Leadership | Orano Med
Our Governing Board is composed of 8 members with profiles combining experience in the area of pharmaceuticals and biotech and Orano's expertise in the nuclear sector.See details»
Orano Med - Crunchbase Company Profile & Funding
Orano Med has opened a new radiotherapy manufacturing plant near Indianapolis. Additionally, Orano Med and Molecular Partners shared positive preclinical data of their DLL3-targeting radio-DARPin therapy candidate MP0712.See details»
The nuclear medicine | Orano
Pierre and Marie Curie knew immediately when they discovered radioactivity how promising it would be for medical research. Bringing progress to the area of nuclear medicine, Orano Med, …See details»
Sanofi and Orano join forces to develop next-generation …
Oct 17, 2024 Sanofi and Orano Med, a subsidiary of the Orano Group and a pioneer in the development of targeted alphatherapies in oncology, have entered into an agreement to …See details»
Orano Med - LinkedIn
Orano Med | 9,557 followers on LinkedIn. Innovative targeted alpha therapy to fight cancer using lead-212 (Pb-212) | Based on an R&D program started in 2005, Orano Med has developed new processes ...See details»
About Us - usa.orano
Headquartered in Washington, D.C., Orano USA is a leading technology and services provider for decommissioning shutdown nuclear energy facilities, used fuel management, federal site …See details»
Orano Announces Leadership Transition in Orano Med
Oct 25, 2024 More information about Orano Med, visit: https://www.oranomed.com. Contacts. Press Office +33 (0)1 34 96 12 15 [email protected]. Investor relations Marc Quesnoy …See details»
Orano Announces Leadership Transition in Orano Med
PARIS, October 25, 2024--Regulatory News: Orano is pleased to announce a significant evolution in the leadership structure of its subsidiary Orano Med, a pioneer in the development of targeted ...See details»
Orano Med Lays Foundations for New Manufacturing Site for the ...
ONNAING, France, February 02, 2024--Regulatory News: Orano Med (a subsidiary of the Orano Group), a pioneer in the development of targeted alpha therapies for oncology, today laid the …See details»
Our mission | Orano Med
Our strategy. Making successful Targeted Alpha Therapy a reality . Orano Med’s strategy has two goals: . developing a robust pipeline of 212 Pb-based therapies,; providing a reliable supply …See details»
Orano Med - Craft
See insights on Orano Med including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Orano Med lays foundations for new manufacturing site for the ...
Feb 1, 2024 Orano Med (a subsidiary of the Orano Group), a pioneer in the development of targeted alpha therapies for oncology, today laid the foundation stone for its ATLab (Alpha …See details»
Orano Med - Overview, News & Similar companies | ZoomInfo.com
Jan 27, 2022 Who is Orano Med. Orano Med is a clinical-stage biotechnology company with the ambition to develop a new generation of targeted therapies against cancer using the un ique …See details»
RadioMedix and Orano Med Complete Patient Enrolment in Phase …
Mar 25, 2024 More information about Orano Med, visit: www.oranomed.com. Contacts Media ContactsRadioMedix, Inc.Izabela Tworowska, PhD.Chief Scientific officer+ 1 713-358 …See details»
Radiomedix and Orano Med Announce the Initiation of the Phase …
Jan 3, 2022 Houston, TX and Plano, TX, Jan. 03, 2022 (GLOBE NEWSWIRE) -- RadioMedix and Orano Med are pleased to announce the initiation of the Phase II clinical trial of …See details»
Orano Med lays foundations for its new facility to produce …
Nov 14, 2024 The France 2030 investment plan. France 2030 reflects a twofold ambition: to sustainably transform key sectors of our economy (healthcare, energy, automotive, …See details»
Orano Med and Orbit Discovery enter Collaboration to discover …
Sep 11, 2023 For further information, please visit: www.orbitdiscovery.com and www.oranomed.com. About Orano Med SAS. Orano Med is a clinical-stage biotechnology …See details»
Orano Med Starts Phase I Trial With Alpha Radioligand Therapy
Jan 4, 2023 Media Contacts Orano Med Jason D. Hurt, MD Chief Medical Officer [email protected] +1 614 886 1698 Halsin Partners Mike Sinclair …See details»